Market Leadership Through customer loyalty with prominent brand identity, living improvement culture and evergreen leaders
Enabling anticipative, accurate & convenient health care for better life
PBPK SUMBAGUT IV 2015
Activity fourth Continuing Education of Clinical Pathology (namely: Pendidikan Berkesinambungan Patologi Klinik/ PBPK) was held for 3 days, and took place on 20 s / d May 22, 2015, at the Hermes Palace Hotel, Banda Aceh-NAD. It’s starting with Clinical workshop event on May 20, 2015, which was followed by a scientific symposium on May 21- 22, 2015.
Events PBPK Sumbagut & NAD IV were regular activity organized by Association of Clinical Pathology Physician Specialists, in particular regional northern Sumatra, including Aceh. The Association in cooperation with the RS Zainul Abidin (RSZA), NAD, have aims to disseminate the latest knowledge or update in the aspect of the field of Clinical Pathology.
Approximately 200 participants attended on this symposium, which mostly come from Aceh and North Sumatra. However the event was attended also by several participants from West Sumatra and DKI Jakarta.
With some speakers participate on PBPK-IV, including Prof. Dr. Hariman Herman, PhD SpPK (K) from Adam Malik Hospital / FK USU Medan, Dr. Buchori SpPK & Dr. Vivi Keumala, SpPK, from RSZA Banda Aceh, Dr.dr. Rikarni, SpPK from RS M. Djamil / FK Andalas University in West Sumatra, also some clinicians of Intensive Care, such Prof. Dr. Hanafi, SpAnKIC also from Adam Malik Hospital / FK USU, Medan who gave a presentation related procalcitonin (PCT).
In this PBPK course, Enseval Medika Prima (EMP), as SBU Kalbe engaged in the marketing and distribution of Medical Devices & diagnostic lab, also supported on the one event, as Lunch symposia, with topics Tacrolimus, therapeuctic drug monitoring assay hosted by dr. Irwan Widjaja, MBIOMED, head of Scientific Support unit of EMP, with the moderator Dr. dr. Rikarni, SpPK of RS M. Djamil / FK Univ Andalas Padang, with the main topic explores profile Thermo Scientific examination assay, which uses in monitoring the use of a dose of Tacrolimus, Cyclosporine and Monophenolic mofertil (MMF) simultaneously with a relatively quick examination through CEDIA assay technology & QMS, focusing primarily diagnostic examination of Tacrolimus.
Using the instrument, tool devices from INDIKO with CEDIA assay and QMS as a means of Therapeutic Drug Monitoring (TDM), especially for immunosuppressant drugs / ISD (immunosuppressive Drugs) monitoring assay with an analyzer tool which can consolidate all tests ISD automatically within one platform, thus providing an improvement in process work / workflow and Turn Around Time (TAT) faster and optimally. '5 ON 1' or One stop shop with CEDIA Cyclosporine C0 and C2 / MPA / and QMS Everolimus and Tacrolimus.
The tool of INDIKO & Assay of Thermo Scientific USA have provides on the position of some benefits or advantages, such as the Small & Smart ISD for platform test.
In addition to transplantation, another indication that inspection can also use this parameter in clinical state autoimmune diseases such as SLE, MS, as well as Rheumatoid Arthritis (RA) who received such treatment.
On the event activities are enlivened and supported by exhibition of some medical devices and diagnostic companies, which one of them was Enseval Medika Prima (EMP), as one of SBU Kalbe group.